Description
The Risk of Ovarian Malignancy Algorithm (ROMA) is a test that helps determine the likelihood of ovarian cancer in women with an ovarian mass. ROMA is a logistic regression model that combines serum levels of two biomarkers, menopausal status, and other factors to calculate a numerical score.
What it does
- Helps determine if an ovarian mass is benign or malignant
- Helps identify women who are at high or low risk for ovarian cancer
- Helps triage patients to gynecologic oncologists
How it works
- Analyzes serum levels of the biomarkers human epididymis protein 4 (HE4) and cancer antigen 125 (CA125)
- Considers menopausal status
- Calculates a numerical score
Fasting not required.